Chemoinformaics analysis of p-coumaric acid-2
Molecular Weight | 276.376 | nRot | 7 |
Heavy Atom Molecular Weight | 252.184 | nRig | 8 |
Exact Molecular Weight | 276.173 | nRing | 1 |
Solubility: LogS | -4.914 | nHRing | 0 |
Solubility: LogP | 4.592 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 46.799 |
nHD | 0 | BPOL | 28.417 |
QED | 0.559 |
Synth | 1.999 |
Natural Product Likeliness | -0.034 |
NR-PPAR-gamma | 0.137 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.938 |
Pgp-sub | 0.01 |
HIA | 0.006 |
CACO-2 | -4.486 |
MDCK | 0.0000205 |
BBB | 0.202 |
PPB | 0.984914 |
VDSS | 0.675 |
FU | 0.0286605 |
CYP1A2-inh | 0.323 |
CYP1A2-sub | 0.16 |
CYP2c19-inh | 0.797 |
CYP2c19-sub | 0.347 |
CYP2c9-inh | 0.864 |
CYP2c9-sub | 0.988 |
CYP2d6-inh | 0.084 |
CYP2d6-sub | 0.358 |
CYP3a4-inh | 0.197 |
CYP3a4-sub | 0.387 |
CL | 8.344 |
T12 | 0.237 |
hERG | 0.034 |
Ames | 0.057 |
ROA | 0.026 |
SkinSen | 0.939 |
Carcinogencity | 0.751 |
EI | 0.971 |
Respiratory | 0.098 |
NR-Aromatase | 0.087 |
Antiviral | Yes |
Prediction | 0.714096 |